Oral Abstract Session:
128. Vaccines: New and Established
Friday, October 9, 2015: 10:30 AM-12:00 PM
Room: 5--AB

Learning Objectives:

-

Tracks: Pediatric ID, Adult ID

Moderators:  Robert Frenck Jr., MD, FIDSA, Cincinnati Children's Hospital Medical Center, University of Cincinnati and Krow Ampofo, MD, FIDSA, FPIDS, University of Utah School of Medicine

Presentations:
10:30 AM
744
Heterologous Prime-Boost Schedules of Replication-Defective Adenovirus Serotype 26 and Modified Vaccinia Virus Ankara Vector Vaccines Expressing Ebola Virus Glycoprotein Are Immunogenic and Well Tolerated in Healthy Adults
Iain Milligan, MRCP ; Malick Gibani, MRCP ; Danielle Campbell, BScN, DTN ; Elizabeth Clutterbuck, PhD ; Richard Sewell, BA ; Emma Plested, - ; Elizabeth Nuthall, BSc ; Merryn Voysey, MBiostat ; Nicola Orzabal De La Quintana, BSc ; Georgi Shukarev, MD ; Carla Truyers, PhD ; Wilbert Van Duijnhoven, MSc ; Kerstin Luhn, PhD ; Macaya Douoguih, MD, MPH ; Katie Ewer, BSc (Hons), PhD ; Adrian V.S. Hill, DM, DPhil ; Brian Angus, MD, FRCP ; Andrew J Pollard, FRCPCH, PhD ; Matthew Snape, MD
10:45 AM
745
Immunogenicity and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Tdap and MCV4 in US Adolescents
Derek Muse, MD ; Shane Christensen, MD ; Prakash Bhuyan, MD, PhD ; Judith Absalon, MD, MPH ; Joseph Eiden, MD, PhD ; Thomas R. Jones, PhD ; Laura J. York, PhD ; Kathrin U. Jansen, PhD ; Robert E. O'neill, PhD ; Shannon L. Harris, PhD ; John L. Perez, MD, MA
11:00 AM
746
Safety, Tolerability and Immunogenicity of a Single Dose 4-antigen or 3-antigen Staphylococcus aureus Vaccine in Healthy Older Adults
C. Buddy Creech, MD, MPH, FPIDS ; Robert W. Frenck Jr., MD, FIDSA ; Eric Sheldon, MD ; David Seiden, MD ; Martin K. Kankam, MD, PhD, MPH ; Edward T. Zito, PhD ; Douglas Girgenti, MD ; Joseph M. Severs, MS ; David Cooper, PhD ; Kathrin U. Jansen, PhD ; Emilio A. Emini, PhD ; William C. Gruber, MD, FIDSA ; Joseph Eiden, MD, PhD ; Annaliesa S. Anderson, PhD ; James Baber, MBChB, MPH
11:15 AM
747
Sustained decrease in rotavirus activity after implementation of rotavirus vaccines through the National Respiratory and Enteric Virus Surveillance System (NREVSS) -- United States, 2000-2015
Negar Aliabadi, MD MS ; Umesh D. Parashar, MBBS, MPH ; Jacqueline Tate, PhD ; Amber Haynes, MPH
11:30 AM
748
Impact of Rotavirus Vaccination on Circulating Rotavirus Genotypes in a State With a Universal Vaccine Policy
Sabina Holland, M.D. ; Sara Nelson, BS ; Penelope H. Dennehy, MD, FIDSA, FPIDS
11:45 AM
749
Changing Trends in Parapneumonic Empyema (PPE) in the United States during the Pneumococcal Conjugate Vaccines Era
Krow Ampofo, MD, FIDSA, FPIDS ; Andrew Pavia, MD, FIDSA, FSHEA, FPIDS ; Chris Stockmann, MSc ; Anne J. Blaschke, MD, PhD, FIDSA, FPIDS ; Adam L. Hersh, MD, PhD ; Emily Thorell, MD, MSCI ; Susan K. Sanderson, DNP ; Pricilla Rosen, BSc ; E. Kent Korgenski, MS ; Judy a. Daly, PhD ; Carrie L. Byington, MD, FIDSA

CME Credits:

ACPE Credits:

ACPE Number:


See more of: Oral Abstract Session
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.